QA: Metavia Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001638287_2018_Metavia_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - Statements of Comprehensive Loss': 13, '00205 - Statement - Condensed Statements of Comprehensive Loss (Calc 2)': 1}}

Graph

Absolute values for 0001638287, Metavia Inc

  xvar xval
0 AssetsCurrent 19,009,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 8,000
4 LiabilitiesCurrent 6,390,000
5 LiabilitiesNoncurrent 3,000
6 remainder_Liabilities 8,683,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,438,000
9 ResearchAndDevelopmentExpense 22,686,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -291,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 19,017,000
1 Liabilities 15,076,000
2 Expenses 33,124,000
3 Revenues 0
4 StockholdersEquity 3,941,000
5 NetIncome -33,415,000
6 ComprehensiveNetIncome -33,415,000
7 BaseVar 33,754,000
8 EconomicCapitalRatiobeforeLimitedLiability -1.46
9 EconomicCapitalRatio 1.19

Edgar->Model Mapping

Feature Distribution

Change over Time